generics

  • Technician working with biosimilars and biologic drugs.
    April 19, 2014  

    NewsHour looks at a revolutionary class of drugs called “biologics.” Americans have been paying more for their benefits than patients in Europe or Asia some say, because the “generic” versions or “biosimilars” have not hit the U.S. market. Dr. Emily Senay looks into why there’s a delay and when American consumers can expect discounts. Continue reading

  • March 25, 2013  

    In other news Monday, The New York Times reported that the CIA has been secretly helping expand military aid shipments to Syrian rebel fighters, assisting Turkey and other Arab states in the increase of weapons and equipment. Also, the Supreme Court heard arguments about drug companies delaying the release of generic drugs. Continue reading